Skip to main content

Sophia Genetics AI

Sophia Genetics said this week that its Sophia AI platform now has radiomics capabilities, which will be combined with the technology's existing genomic analysis capabilties. The new capabilities are based on mechanistic and mathematical modelling and help to predict the evolution of a tumor (size, volume, and location) by analyzing quantitative image features from two or more consecutive standard-of-care medical images (i.e. PET-scans, MRIs, x-rays and more). Clinical proofs of concept have already been executed on hundreds of patients' cases for lung, kidney, glioma, and meningioma, and the technology should soon be applied to any solid tumor, the company said.